ClinicalTrials.govpublic full text
Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
nonsmall cell lung cancer, non small cell lung cancer, egfr-tki resistance, apatinib, anti-angiogenesis drugs, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 862317
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.